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Cardiac arrest, characterized by the loss of mechanical activity of the heart, is a 
life-threatening medical condition that is almost always fatal if not treated immediately. 
The protocols for cardiopulmonary resuscitation used by emergency medical personnel 
during out-of-hospital cardiac arrests do not account for cardiac and thoracic anatomic 
variation when positioning chest compressions. This study will examine whether 
evaluating chest compression efficacy using transthoracic echocardiography in the 
prehospital setting will increase the rates of survival to hospital admission in adults 
suffering atraumatic out-of-hospital cardiac arrest. We will recruit paramedics from four 
emergency medical services agencies to participate in a prospective crossover study and 
be trained in basic echocardiography to be used in the field. The results of this study may 
support imaging in out-of-hospital settings to promote more effective cardiopulmonary 











Cardiac arrest is a deadly condition defined as the loss of mechanical activity of the 
heart confirmed by the absence of signs of circulation.1 Over 350,000 people are treated 
annually for cardiac arrests that occur out-of-hospital.1 Unfortunately, survival rates for 
out-of-hospital cardiac arrests (OHCA) are quite low; only about 7.6% of adults 
sustaining cardiac arrest outside of a hospital survive to be discharged from the hospital.2 
Survivability of an OHCA varies widely depending on several factors, including 
bystander cardiopulmonary resuscitation (CPR), availability and early use of an 
automated external defibrillator (AED), and type of electrical rhythm present during 
cardiac arrest.2 The timely application of high-quality chest compressions as part of CPR 
has been proven to increase the likelihood of survival. Rapid and effective CPR may be 
one of the reasons that in-hospital cardiac arrest survival rates are as high as 50%, which 
is considerably higher than that of OHCAs.3 Patients who suffer cardiac arrest outside of 
the hospital have low odds of survival unless the cardiac arrest is witnessed, CPR is 
initiated quickly and performed effectively, and emergency medical services (EMS) are 
activated promptly to ensure early defibrillation and advanced cardiac life support 
(ACLS). The survivability of OHCA remains quite low, even in best case scenarios. Due 
to the relatively small window of time in which a patient suffering an OHCA can survive, 
many of the interventions aimed at improving survival rates have been incorporated by 
EMS employees, specifically emergency medical technicians (EMTs) and paramedics. 
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One of the newest diagnostic tools to be introduced in the prehospital setting is 
the portable ultrasound device. Lightweight and low-cost, these devices are easily 
integrated into the prehospital assessment and even during resuscitation. Several studies 
examining the feasibility of prehospital ultrasound use have proven that paramedics can 
be trained in basic echocardiography in a short period of time and apply these skills to 
obtain high-quality images in the prehospital environment.4-6 Several prospective 
observational studies have also been performed to determine the effect of paramedic-
guided echocardiography during cardiac arrest.7,8 Unfortunately, there are currently no 
published randomized controlled studies that examine the effect of prehospital 
echocardiography on patient outcomes, such as survival, in atraumatic cardiac arrest.9  
1.2 Statement of the Problem 
 
OHCA survival rates in non-traumatic adult arrests are only approximately 7.6% 
nationwide2. In New Haven, the most recent data on survival show that 9.2% of patients 
suffering non-traumatic cardiac arrest survive to discharge, and 11.2% survive to hospital 
admission.10 Cardiac arrest survival increases with timely and effective CPR. There are 
currently no imaging modalities widely available to prehospital clinicians to determine 
whether CPR is being performed effectively in cardiac arrest.  
In a recent Yale hypothesis-generating series of five patient cases, it was found 
that unique patient anatomy limited the effectiveness of resuscitation with either manual 
or automatic chest compression devices that did not directly cause compression of the left 
ventricle, though properly positioned according to standard protocol.11 Focused 
transthoracic echocardiography in the emergency department using parasternal long axis 
and subxiphoid views showed that positioning of chest compressions in the standard 
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location compressed structures that were sub-optimal, such as the aorta and right heart.11 
Swine models have shown that optimal hemodynamic parameters are achieved when the 
left ventricle of the heart is directly compressed during CPR, thus enhancing the 
likelihood of return of spontaneous circulation (ROSC).12 In the five cases published by 
Dr. Liu et al., repositioning of chest compressions directly over the left ventricle using 
visual information gathered from the echocardiogram resulted in ROSC in four patients, 
and determined an etiology for the abrupt cardiac arrest in the fifth patient. 
Unfortunately, in all five cases spontaneous circulation either could not be maintained for 
a sufficient period of time, or the patient suffered significant neurological compromise 
due to prolonged inadequate efforts at resuscitation.11 Currently, there have not been any 
randomized studies performed on the efficacy of CPR positioning using focused 
transthoracic echocardiography, either in the hospital or in the prehospital setting. In 
summary, standard CPR positioning does not take natural anatomical variation in patients 
into account; without an imaging modality to ascertain whether the correct anatomy is 
being compressed, these patients have a very small likelihood of survival. 
1.3 Goals and Objectives 
 
EMS personnel provide rapid care to patients suffering OHCA. The rapid initiation of 
uninterrupted effective CPR has been proven to improve likelihood of patient survival in 
OHCA. By teaching paramedics to perform a basic echocardiographic assessment using a 
portable ultrasound device, they can quickly assess whether the left ventricle of the heart 
is being compressed effectively by the person or device performing CPR without 
interrupting compressions. Effective compression of the left ventricle increases the 
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likelihood of return of spontaneous circulation and hemodynamic stability, thus 
increasing the likelihood of survival to hospital admission. 
1.4 Hypothesis 
 
We hypothesize that paramedic-performed focused transthoracic echocardiography in 
cardiac arrest to determine accuracy of chest compression placement during CPR will 
result in higher rates of survival to hospital admission when compared to standard care as 




Prehospital - occurring before or during transportation to a hospital 
Out-of-hospital cardiac arrest (OHCA) - the loss of functional cardiac mechanical 
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A systematic literature search was performed using multiple databases, including 
Ovid (Medline), EMBASE, Scopus, Cochrane Medical Library, and Pubmed. The 
literature search was performed between December 2019 and January 2020 using the 
following terminology. Key terms used to search databases with respect to cardiac arrest 
included out-of-hospital cardiac arrest, OHCA, heart arrest, cardiac arrest, 
cardiopulmonary resuscitation, and CPR. Terms regarding imaging included 
ultrasonography, ultrasound, POCUS, FEEL, echocardiography, echocardiogram, echo, 
and transthoracic echocardiography. Key terms regarding the setting of the intervention 
included emergency medical services, EMS, paramedic, emergency medicine, emergency 
medical technician, prehospital, pre-hospital, and out-of-hospital. Key terms used to 
search for specific protocol parameters included crossover study design, cross-over, and 
cross over. Furthermore, searches were performed for the specific outcome being studied, 
including survival, survival to admission, and survival to hospital admission. The search 
was limited to adult population (ages 18 and older), articles published within the last ten 
years, and articles in English. Article abstracts were subsequently screened for relevance.  
2.2 Overview of the Burden of Out-Of-Hospital Cardiac Arrest 
 
OHCA is frequently encountered and treated by emergency medical personnel in 
the United States. 2019 estimates from the American Heart Association state that the 
annual incidence of EMS-assessed OHCA in adults in the United States is 356,461 (95% 
CI = 350,349-362,252).1 National estimates of survival to hospital discharge in 2017 
7 
 
from the Cardiac Arrest Registry to Enhance Survival (CARES) database were a dismal 
10.4% among adults.2 Conversely, the in-hospital cardiac arrest rate of survival to 
discharge is 25.6% (based on data from 311 US hospitals)3. There are large regional 
variations in OHCA survival to hospital discharge, ranging from 3.4% to 22.0% (median 
odds ratio = 1.40, 95% CI = 1.32-1.46).4 Based on 2018 calculations from the CARES 
database, the national rate of survival to hospital admission following OHCA was 
28.2%.2 These data indicate that there is room for improvement in the treatment of 
OHCA, and that perhaps it is possible to increase patient survival rates.  
Survivors of cardiac arrest also suffer from many functional impairments that 
ultimately reduce their quality of life.5,6 Among the sequelae reported one year post-event 
by 141 patients in a cohort that survived cardiac arrest, 13% displayed severe cognitive 
deficits, 15% reported anxiety and depression, 28% displayed symptoms of posttraumatic 
stress disorder (PTSD), and 52% complained of severe fatigue.7 This study demonstrates 
that survival of cardiac arrest is not without long-term consequences that affect quality of 
life.  
2.3 Overview of Ultrasonography in the Prehospital Setting 
 
 As point-of-care ultrasound (POCUS) becomes more ubiquitous in both the 
emergency department and in prehospital settings, clinicians have found new ways to 
incorporate these devices into patient assessments to change the course of treatment. The 
utility of prehospital POCUS has been most critically evaluated in the diagnosis and 
treatment of cardiac arrest, trauma, and dyspnea.8 The findings regarding POCUS use in 
the setting of cardiac arrest will be discussed below in the next section. A recent 
systematic review detailed the findings of several studies that found utility in POCUS for 
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trauma patients.8 A prospective trial by Press et al. found that the specificities for 
helicopter-based emergency medical personnel to identify hemoperitoneum and 
pneumothorax using POCUS examination were 94.1% (95% CI = 89.2%-97%) and 
99.5% (95% CI = 98.2%-99.9%), respectively.9 Sensitivities, on the other hand, were just 
46% (95% CI = 27.1%-94.1%) and 18.7% (95% CI 8.9%-33.9%), respectively.9 These 
data suggest that the helicopter-based emergency medical personnel participating in this 
study were very good at identifying disease-free anatomy, but were much less accurate at 
identifying pathological states. Another study found that identification of pneumothorax 
by non-physician air medical personnel using prehospital POCUS had an overall 
accuracy of 91% (95% CI = 85-95%) when compared to chest computed tomography, 
with a specificity of 96% (95% CI = 90-98%) and a sensitivity of 68% (95% CI = 46-
85%).10 Once again, these data suggest that while prehospital clinicians are able to 
adequately view normal anatomy on ultrasound, they struggle with identifying pathology. 
Further training may be required to focus on the presentation of pathology in future trials. 
Furthermore, the prehospital clinicians who participated in the study were composed of 
flight nurses and paramedics, with a mean of 10.6 years of experience in air medical 
services.10 The level of experience may dictate the skill with which these clinicians are 
able to use POCUS. Additionally, flight nurses have different educational backgrounds 
and a slightly different scope of practice than paramedics, and thus different strengths and 
weaknesses. 
POCUS has also been used in the evaluation of dyspnea, especially in patients 
with multiple comorbidities. In patients with dyspnea, POCUS can be used to distinguish 
dyspnea caused by congestive heart failure (CHF) from dyspnea caused by chronic 
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obstructive pulmonary disease (COPD).11 This study by Neesse et al. determined that 
POCUS-elicited pleural effusion was demonstrated in 100% of patients with dyspnea 
caused by CHF, whereas it was only seen on 20% (p<0.01) of ultrasound recordings 
performed in patients having COPD exacerbations, thus allowing emergency medical 
clinicians to correlate other clinical findings to narrow their differential diagnosis.11 In 
the prehospital setting, there are limited modalities available to discern causes of 
dyspnea. Tools that are frequently used in the hospital, such as arterial blood gases and 
chest x-rays, are simply not available in prehospital medicine. With only a few tools 
(such as physical exam, capnography, and pulse oximetry) at their disposal, paramedics 
in prehospital settings cannot easily discern the etiology of dyspnea and may be inclined 
to withhold or delay interventions such as fluid resuscitation, for fear of exacerbating the 
symptoms. The use of POCUS in this setting may provide prehospital clinicians with the 
opportunity to narrow a broad differential diagnosis and deliver appropriate interventions.  
2.4 Use of Echocardiography in Cardiac Arrest 
 
Portable ultrasound devices have become increasingly prevalent in the prehospital 
setting due to their relatively low cost, durability, and portability.12 Additionally, portable 
ultrasound devices are accurate. One study by Vourvouri et al. showed 100% (kappa = 
0.969) agreement with standard echocardiographic findings using portable ultrasound 
devices for effusion, and 93% (kappa = 0.871) agreement for left ventricle function and 
wall motion abnormalities.13 These data suggest that the portable ultrasound device is an 
effective substitute for traditional echocardiographic equipment when the latter is 
unavailable. Another study by Rugolotto et al. found a sensitivity of 97% and a 
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specificity of 99% for echocardiographic evaluation of moderate to severe anatomic 
pathology using a portable ultrasound device.14  
There have been several influential studies performed to investigate the effects of 
using ultrasonography in cardiac arrest on various outcomes, such as effect on treatment 
decision and correlation of cardiac movement with survival.15,16 Unfortunately, there 
have been no randomized, controlled studies to date that compare survival in groups 
receiving prehospital echocardiography for OHCA to controls. A selection of prospective 
observational studies has formed the basis of our understanding of prehospital 
echocardiography thus far. In a study of 42 patients, Aichinger et al. found that the use of 
echocardiography in non-traumatic OHCA to view cardiac movement (versus cardiac 
standstill) predicted survival with a 97.1% positive predictive value.17 This study found 
that of the 32 patients who had complete cardiac standstill on the echocardiographic 
assessment during resuscitation, only one (3.1%) survived to hospital admission, whereas 
four out of the ten patients (40%) with cardiac movement on the assessment survived to 
hospital admission (p=0.008).17 This suggests that echocardiography can be used to 
evaluate cardiac motion to predict prognosis in cardiac arrest patients. Using this 
information, clinicians can use echocardiography to confirm lack of cardiac motion in 
cases where termination of resuscitative efforts may be questionable. Many emergency 
physicians now use bedside echocardiography as a means to support the decision to 
terminate resuscitation.18 An observational study by Breitkreutz et al. in the prehospital 
setting used a similar type of echocardiographic assessment to view cardiac motion.19 
The authors found that the FEEL (focused echocardiographic evaluation in life support) 
assessment was useful in differentiating between true cardiac arrest and profoundly low 
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cardiac output, a distinction that can significantly alter patient management.19 Although 
ACLS protocols dictate that a clinician should seek to find a cause of etiology of cardiac 
arrest, there are no specific guidelines that address how to do so.20 Breitkreutz et al. found 
that echocardiographic findings from the FEEL assessment resulted in a warranted 
change in patient management 89% of the time.19 Peri-resuscitative echocardiography in 
the hands of prehospital clinicians can provide a tool to determine the etiology of a 
cardiac arrest, when no clear etiology is found with traditionally available tools. The 
FEEL assessment can reveal conditions such as tamponade, profound hypovolemia, and 
myocardial insufficiency as causes for abrupt cardiac arrest.19 Breitkreutz et al. found that 
introducing this peri-resuscitative echocardiographic assessment had potential to be 
useful in the prehospital setting, but had thus far mainly been taught to physicians in 
acute care specialties.19 Further implementation in the prehospital setting may be useful, 
but remains unproven given that no randomized trials using ultrasound technology and its 
effect on survival currently exist. The study by Breitkreutz et al. was not randomized and 
was limited by the fact that it did not independently review all images gathered due to 
technical limitations. Furthermore, the study was conducted in Germany and employed 
emergency physicians to perform the peri-resuscitative echocardiographic assessment. 
Due to the much smaller number of emergency physicians practicing prehospital 
medicine in the United States (when compared to paramedics and EMTs), it is difficult to 
generalize these results to an American paramedic-based prehospital medicine system.  
Based on the findings of Breitkreutz et al., a similar study set in a Dutch 
helicopter emergency medical service enrolling 56 patients recently found that a 
prehospital echocardiographic assessment resulted in treatment changes in 88% of 
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cardiac arrests.16 In 32 patients, the ultrasound findings supported the termination of 
resuscitation.16 In 21 patients, the ultrasound findings supported the continuation of 
resuscitation efforts.16 This study was also key in elucidating some of the limitations of 
introducing a peri-resuscitative intervention in a high stress environment. It was found 
that a high number of case report forms, designed to record information about time of 
cardiac arrest, start of basic life support (BLS), initial observed heart rhythm, timing of 
ROSC or termination of resuscitation, were not filled out by the emergency physicians 
staffing the EMS service. The speculated reasons for this lack of data were 
“nonadherence to the protocol, a lack of time due to subsequent missions, or plain 
forgetfulness,” as well as “dismissal of the entire procedure due to poor image quality, or 
the impression the scan contributed nothing to patient management,” thus introducing 
selection bias.16 Unfortunately, this suggests that such limitations may occur in other 
studies that take place in the prehospital setting treating cardiac arrest if proper adherence 
protocols are not implemented.     
Portable echocardiography may also be useful in dictating the direction of patient 
management beyond just the continuation or termination of resuscitative efforts. In a 
retrospective analysis of the REASON study, Gaspari et al. implemented a bedside 
echocardiographic assessment in patients in PEA (pulseless electrical activity) arrest. 
Their findings helped identify a subset of patients with organized cardiac activity who 
responded well to continuous adrenergic agents, resulting in higher rates of survival to 
hospital admission.21 Although this study was not randomized and included patients 
suffering cardiac arrest in the emergency department, as well as out-of-hospital, it is one 
of the few studies available that examines how using echocardiography during cardiac 
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arrest to determine treatment plans based on cardiac activity affected survival to hospital 
admission. Patients with organized cardiac activity (as seen on echocardiography) treated 
with epinephrine had a survival to hospital admission rate of 37.7%, compared to 45.5% 
for patients with organized rhythms treated with standard ACLS (p<0.005).21 Patients 
with disorganized activity treated with standard ACLS interventions demonstrated a rate 
of survival to hospital admission of 17.9%, compared to 0% for  patients with 
disorganized activity receiving epinephrine (p<0.005).21 Although this trial did not 
directly study the relationship between peri-resuscitative echocardiography and survival 
to hospital admission, it did use echocardiography as a tool to view cardiac activity, and 
determined that this procedure may have beneficial effects on survival.  
2.5 Feasibility of Implementing Paramedic-Guided Echocardiography in a 
Prehospital Environment 
 
Determining whether prehospital clinicians can successfully be taught to perform 
the assessment must be carefully considered as one of the challenges associated with 
implementing a new assessment in the prehospital setting. Several studies examining the 
effectiveness of echocardiography in the prehospital setting employed emergency 
physicians to perform the echocardiographic assessment.19,22 This has both advantages 
and disadvantages. Most emergency physicians are already competent in emergency 
ultrasound and echocardiography, and only need a minimal amount of supplemental 
training to implement this intervention in the prehospital setting.23 For example, 
emergency physicians employing point-of-care echocardiography in an ICU setting were 
able to obtain adequate images in 100% of the 151 enrolled patients.24 In most European 
countries, emergency physicians are employed to deliver the bulk of prehospital care 
under the Franco-German model of EMS delivery.25 However, in the United States, 
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emergency physicians who practice prehospital care are relatively uncommon.25 Instead, 
paramedics and EMTs make up the majority of clinicians who deliver prehospital care.  
It would be very difficult to conduct an adequately powered study with a 
sufficiently large sample size using only emergency physicians to perform prehospital 
interventions. Fortunately, in acknowledgement of this limitation, several studies have 
also examined the feasibility of educating paramedics to successfully perform 
echocardiographic assessments. Chin et al. found that 75% of paramedics were able to 
identify at least one ventricle on echocardiographic assessment after a short 2 hour 
training course, but recommended further training.26 Heegaard et al. implemented a six-
hour long training course for paramedics (including three hours of practical training and 
additional one hour of refresher training) in Focused Assessment Sonography in Trauma 
(FAST) and abdominal aortic exams.27 The authors found that paramedics were able to 
obtain adequate images in 92% of patients receiving the FAST exam (which includes a 
cardiac exam component), as verified by experienced sonographers.27 The PUCA 
(Paramedic Ultrasound in Cardiac Arrest) study, published in 2017 by Reed et al., set out 
not only to determine whether paramedics could be trained to perform and interpret 
echocardiography while delivering life support, but whether they could perform the 
echocardiographic assessment during a short pulse-check window, and whether this 
intervention affected the quality of cardiac arrest care.28 The training period for 
paramedics in this trial consisted of a two-hour lecture alongside four hours of practical 
sessions and simulations. The study found that paramedics obtained an adequate view of 
the heart 80% of the time on the first try and 100% of the time on the subsequent 
attempt.28 These views were deemed excellent/good or satisfactory 68% of the time on 
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the first try.28 However, a view was only obtained within the 10-second pulse check 
timeframe approximately 44% of the time.28 The study also found that performing the 
echocardiographic assessment prolonged hands-off time during CPR to 17 seconds, 
which is unacceptable per ACLS guidelines.20 It was determined that while paramedics 
could feasibly be taught to perform adequate echocardiographic assessments during life 
support with satisfactory views, this intervention also delayed life-saving care in some 
cases.28 Fortunately, it is less likely that this issue will arise in our proposed trial because 
paramedics will be instructed to perform the echocardiographic assessment while CPR is 
ongoing, thus removing the need to perform the assessment during the short pause in 
compressions.  
2.6 Review of Confounding Variables 
 
There are many potential confounding factors to consider when studying the 
effect of an intervention in cardiac arrest on survival. Due to the unpredictable and 
demanding nature of delivering life support outside of a hospital with limited available 
tools, many factors may affect patient outcomes, including survival. Certain aspects of 
the EMS system itself create unexpected effects on patient outcomes. For example, many 
ambulance services, including those that are to be included in this trial, have crews of two 
individuals that respond to 9-1-1 calls. Due to the demanding nature of caring for a 
patient in cardiac arrest, it is often the case that a second crew of two individuals will 
respond to the same call to provide necessary assistance. However, this may not always 
be possible depending on the call volume or staffing available at that point in time. In a 
study where one paramedic is designated to obtain an echocardiographic assessment 
during cardiac arrest, it may be possible that more crew members are required to deliver 
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adequate care to the patient. In this case, a crew of four members will almost inevitably 
deliver better care than a crew of two, and this may affect the patient’s survival. A study 
by Sondheim et al. investigated the optimal number of crew members needed to collect 
sufficient data from a new smartphone application designed to assist EMS personnel in 
recording the timing of interventions performed.29 Using simulations, it was found that as 
crew sizes increased from three to four members, totals delays in care time decreased 
from 13.43 to 2.13 seconds (p<0.001).29 Similarly, increasing group size correlated to an 
increase in the number of interventions recorded in the application (p=0.009).29 The 
greatest improvements were seen between groups of three to groups of four. It was 
determined that the application should not be used in groups of less than four due to the 
increased likelihood of insufficient entries recorded and delays in care time. The 
application from this study demonstrates that introducing a novel intervention in a 
prehospital setting may add to the demand that EMS clinicians experience when 
delivering care in the field. As the number of crew members increases, tasks can be 
delegated and shared to ensure that patient care is not compromised. In our study, it will 
be necessary to ensure that all paramedics responding to cardiac arrest calls are able to 
work with an appropriate number of team members to ensure proper patient care delivery.    
The level of experience of the paramedic performing the intervention is another 
variable that may have a confounding effect on both willingness and ability to use 
transthoracic echocardiography, as well as survival outcomes. A study of ambulance 
crews’ length of experience and its effect on patient survival by Soo et al. found that 
patients’ chances of survival increased once EMTs had 4 or more years of experience 
(odds ratio 2.71, 95% CI 1.17-6.32, p=0.02) when compared to EMTs with less than a 
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year of experience.30 Additionally, patients’ chances of survival increased when 
paramedics had just one or more years of experience (odds ratio 2.68, 95% CI 1.05-
6.82, p=0.04) when compared to paramedics with less than a year of experience.30 
However, a more thorough systematic review by Dyson et al. found that there was no 
clear evidence that EMS practitioner career experience or exposure to OHCA was 
associated with survival rates.31 This was due largely in part to the limitations of the 
studies reviewed, which included a lack of controlling for confounding. Although data on 
whether clinician experience affects survival outcomes is inconclusive, this is a 
confounder that should be controlled for during the final data analysis portion of the 
study. 
Studies have also shown that rates of survival in cardiac arrest are statistically 
different based on race and socioeconomic status. In a study of 4053 cardiac arrests in 
New York City, it was found that age-adjusted survival to hospital admission was 
significantly higher in Caucasians (11.3%) when compared to African-Americans (6.0%, 
p<0.01). Similarly, Caucasians also had a higher survival to hospital admission rate  
when compared to Hispanics (8.6%, p<0.01).32 OHCA also occurs much more frequently 
in poorer populations; OHCA rates were found to be nearly double (incidence rate ratio 
1.9, 95% CI = 1.8-2.0) in census tracts from the lowest socioeconomic quartile when 
compared to the highest socioeconomic quartile.33 According to data from the CARES 
database, men are more likely to suffer non-traumatic OHCAs, composing 62.1% of 
OHCA patients treated by EMS in 2018.34 Conversely, women made up just 32.9% of 
OHCA patients.  
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Comorbidities are another factor that has strong influence over survival from 
cardiac arrest. In particular, obesity is likely to be a confounding variable as it not only 
has an effect on survival, but also presents a challenge for clinicians attempting to obtain 
images on echocardiography due to body habitus. In a prospective cohort of 81,722 
women, BMI of 21.0-24.9 was associated with a decreased risk of sudden cardiac death 
(RR=0.27) when compared to individuals with a BMI >35 (RR=1 p<0.01).35 Another 
comorbidity that is common in those suffering OHCA is atherosclerosis. In a large study 
of 1,274 patients occurring over the course of 10 years, patients suffering OHCA were 
subjected to imaging (CT scan or coronary angiography) in the hospital.36 It was found 
that 61% of patients who had suffered OHCA had at least one significant coronary lesion 
that was thought to have contributed to cardiac arrest.36  
Despite the wide variety of confounding variables associated with studies set in a 
prehospital setting, the influence of these variables will be minimal due to the crossover 
design of this trial. Participants will be matched, thus minimizing the effect of 
demographic and comorbid condition confounding. Many trials with a crossover design 
have a carryover effect inherent to the design of the trial that may act as a confounding 
variable. Fortunately, the intervention used in our trial will not have this effect because 
echocardiography will not have any lasting effects on the individual. Therefore, it will 
not be necessary to incorporate a wash-out period in the study design.  
2.7 Review of Relevant Methodology 
 
 The following sections will include reviews of methodology used in other 
prominent trials relevant to the intervention and outcomes of our proposed study.  
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2.7.1 Selection of Intervention 
 
 As discussed in previous sections, the use of portable ultrasound devices in the 
prehospital setting has been of great interest to many researchers. The advent of portable, 
affordable, and durable imaging has created an opportunity to implement a new imaging 
tool earlier in the patient care process, prior to initiation of care in the emergency 
department. As previously discussed, portable ultrasound has been amply studied in the 
applications of cardiac arrest, trauma, and dyspnea.8 One study in particular found a 
relatively novel use for portable ultrasound that seemed potentially applicable to the 
prehospital setting. In a study of five patient cases in 2019, Liu et al. used portable 
ultrasound devices to perform a very simple echocardiographic assessment of the heart 
while chest compressions were performed, to determine whether the left ventricle was 
adequately compressed.37 This study had several limitations, not least of which was its 
strictly observational nature and small sample size of five patients. No conclusions about 
patient outcomes could realistically be drawn from this small cohort. However, this study 
did introduce an echocardiographic assessment that could be performed in the peri-
resuscitative state without the need for pausing chest compressions. A previous study by 
Reed et al. implementing an echocardiographic assessment during cardiac arrest found 
that the addition of this new intervention during the 10 second “pulse check” window 
resulted in longer pauses in CPR, which was deemed unacceptable.28 However, the 
assessment proposed by Liu et al. does not require a pause in compressions, mitigating 
the risk of delay in patient care.37 Additionally, the assessment proposed by Liu et al. was 
relatively simple; it involved the use of modified parasternal long axis, apical four-
chamber, and subxiphoid views to view the heart while compressions were in progress. 
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Given the feasibility of teaching prehospital clinicians to perform similar assessments, it 
appeared likely that prehospital clinicians could also learn to obtain the described views 
with CPR in progress.26-28    
2.7.2 Review of Study Design, Primary Outcomes, and Secondary Outcomes 
 
The choice to perform a prospective randomized crossover study stemmed from 
the use of crossover designs in other studies employing emergency medical personnel in 
OHCA. A 2015 study by Nichol et al. enrolled patients suffering OHCAs into a trial 
studying the effect of continuous versus interrupted chest compressions on survival to 
hospital discharge.38 This study was implemented within the network of clinical sites of 
the Resuscitation Outcomes Consortium, which included 114 EMS agencies across North 
America. This expansive study allowed for a very large sample size, and the crossover 
design minimized the effect of confounding variables due to matching. Of note, the 
authors stated that some between-group differences were found in the characteristics of 
patients, but these differences were attenuated through post hoc adjustment. As is 
proposed in our study, randomization occurred at the institutional level, with EMS 
agencies being assigned to individual randomization clusters. The primary outcome in 
this study was rate of survival to hospital discharge, with secondary outcomes including 
rates of transport to hospital, ROSC at ED arrival, admission to hospital, survival to 24 
hours, days of hospital-free survival, discharge home, and neurological function based on 
modified Rankin scale.38 Many of the outcomes studied in this trial are also proposed in 
our study due to similarities in the population (patients suffering OHCA). 
Another strong study published by Hallstrom et al. examined the effect of manual 
versus mechanical chest compressions on survival to four hours after the 9-1-1 call.39 
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Although this older study was published in 2006, it remains one of the few randomized 
controlled studies that examines the effect of a peri-resuscitative intervention on survival. 
Much like the trial published by Nichol et al., this study employs EMS personnel to 
implement an intervention in patients suffering OHCA and uses a cluster-randomized 
crossover design. The authors cite the “cost and inconvenience” of moving and carrying 
the mechanical chest compression device as one of the primary reasons for the crossover 
design.39 Similar to our proposed study, the crossover design allows researchers to 
purchase half the amount of equipment needed for the intervention, since groups in the 
clusters will switch protocols every specified time period. Furthermore, the cluster 
randomization technique ensures that equipment can be swapped every few weeks or 
months, rather than at every 9-1-1 response. The primary outcome in the Hallstrom study 
was rate of survival to four hours after the 9-1-1 call, with secondary outcomes including 
rates of survival to hospital discharge and neurologic function using a cerebral 
performance score.39 Because survival to hospital discharge tends to be so rare, the 
primary end point we have proposed in our study is survival to hospital admission. This 
outcome is quite similar to the primary outcome in the study by Hallstrom et al., because 
most patients who survive an OHCA in the emergency department will likely be admitted 
to the hospital within less than 24 hours.  
Additional studies that propose implementing new interventions during OHCA 
have used mannequins or simulations as a substitute for real patients.40-42 This has the 
benefit of testing outcomes such as chest compression depth, ratio of adequate 
compressions, hands-off time, and clinician fatigue in the EMS setting, without 
endangering patients.40 Unfortunately, the use of mannequins in OHCA trials precludes 
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the ability to measure vital outcomes such as survival and neurological status, and 
reduces generalizability. In order to study the effect that transthoracic echocardiography 
has on the survival of patients suffering OHCA, we have opted to enroll qualifying 
patients in our study, rather than use mannequins.   
 
2.7.3 Inclusion and Exclusion Criteria 
 
The exclusion criteria in our trial aim to exclude primarily patients who are of a 
vulnerable population, those who suffered traumatic arrests, or those who cannot or do 
not wish to be resuscitated. The exclusion criteria implemented by Nichol et al. were 
detailed by Brown et al. in a 2016 manuscript.38,43 The populations selected for exclusion 
included:  
“patients with an EMS witnessed arrest; a written advance directive to not 
resuscitate; blunt, penetrating, or burn related injury; obvious cause of arrest is 
asphyxia, respiratory (asthma), drowning, strangulation, hanging, foreign body 
obstruction, or mechanical suffocation; uncontrolled bleeding or exsanguinations; 
known prisoners; known pregnancy; non-ROC EMS agency/provider first to 
initiate chest compressions or place pads; mechanical compression device used 
before any manual CPR by ROC personnel; advanced airway prior to ROC 
agency arrival; pre-existing tracheostomy; or a priori opted out from resuscitation 
research.”38,43  
These criteria closely match those proposed in our trial. Due to very low survival rates 
(ranging 0-3.1%), patients with cardiac arrest of a traumatic etiology are usually either 
excluded from OHCA trials, or studied separately.44 Children, pregnant women, and 
prisoners are vulnerable populations that are also frequently excluded from such trials. 
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Hallstrom et al. used similar exclusion criteria as those used in the study by Nichol et al., 
with the addition of excluding patients who had had recent surgery.39 Though the authors 
do not specifically address why patients with recent surgery were excluded, presumably 
this may be because patients with recent surgery may have characteristics that resemble 
those of patients who suffer traumatic cardiac arrests.  
2.7.4 Baseline Characteristics of Patients 
 
Many factors may affect survival in patients who suffer OHCA. Besides those 
demographic qualities that were discussed earlier in the review of confounding variables, 
many aspects of a cardiac arrest can affect whether an individual survives. Nichol et al. 
analyzed the following pretreatment characteristics in their study of the effect of 
continuous versus interrupted chest compressions on survival to hospital discharge: age, 
sex, obvious cause of arrest, arrest occurring in public location, witness status, bystander-
initiated CPR, time from dispatch to first arrival of EMS, advanced life support on scene, 
and study site.38 In the post-treatment characteristics, the authors included time between 
arrival of EMS and start of CPR, first rhythm (shockable vs. non-shockable), number of 
shocks given, prehospital intubation, CPR <6 min or until ROSC, drugs administered 
before arrival at hospital, and hospital procedures.38 Many of these characteristics also 
encompassed sub-characteristics to further delineate what factors may have affected 
survival.38 However, this study had a massive sample size (26,148), more than 10 times 
the sample size of the study proposed here.   
 Hallstrom et al. similarly designed a randomized controlled study implementing 
an intervention in the population of adult patients suffering OHCA and studying its effect 
on survival. The baseline characteristics analyzed in this study were similar but were not 
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separated by pre- and post-treatment characteristics.39 The baseline characteristics 
included here were age, sex, body type (thin, normal, obese, morbidly obese), witness of 
arrest, CPR performed by bystander, public location of arrest, rhythm (shockable vs. non-
shockable), time from 9-1-1 call to unit arrival, time from 9-1-1 call to initial rhythm 
assessment, time from 9-1-1 call to first shock, number of compressions, proportion of 
first 5 minutes on ECG with compressions, advanced airway placed, IV line inserted, 
epinephrine/vasopressin/bicarbonate administered, death on scene, transport to hospital, 
and hypothermia therapy.39  
Many of the baseline characteristics analyzed in our proposed study were drawn 
from the two above studies. Although the authors of these studies proposed different 
interventions than ours, they studied similar outcomes in a similar population with strong 
randomized study designs with crossover. A prospective cohort study by Stiell et al. 
examined the optimal chest compression depth by reviewing data from the ROC 
PRIMED trial to correlate chest compression depth with survival.45 The baseline 
characteristics were more limited than those analyzed by the Nichol and Hallstrom 
studies, but incorporated age, sex, bystander witness, bystander CPR, time to scene, time 
to first shock, rhythm type, and other EMS interventions. Based on data from these 
studies, we were able to compile a number of baseline characteristics to be analyzed in 
the final data analysis portion of our proposed study.  
2.7.5 Randomization Techniques 
 
Data from the Nichol et al. trial and the Hallstrom et al. trial once again guided 
the selection of randomization technique in our proposed study, due to the use of the 
randomized crossover design in both trials. Nichol et al. enrolled 114 participating EMS 
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agencies, which were grouped into 47 clusters.38 The clusters of agencies were 
subsequently randomly assigned to perform continuous chest compressions or interrupted 
chest compressions in a 1:1 ratio. Every six months, each cluster was crossed over to the 
other resuscitation strategy. Though our proposed study will enroll only four EMS 
agencies, these too will be clustered to include two in each cluster, which will then be 
randomized to intervention or control in a 1:1 ratio. Cluster randomization was also used 
by Hallstrom et al., with EMS agencies assigned to clusters within their site, and 
subsequently randomized to either control (manual CPR) or intervention (mechanical 
chest compression device) in a 1:1 ratio.39 Crossover occurred at specified time intervals 
ranging from four weeks to two months. This randomization technique offers both 
convenience and effectiveness of intervention implementation in the setting of 
prehospital care. Hallstrom et al. specifically noted that the crossover design with cluster 
randomization allowed for convenience of device transfer.39 In our proposed trial, this 
randomization technique combined with the study design allows for the purchase of 
fewer devices, and less time spent transferring devices between individuals. Perhaps even 
more importantly, cluster randomization at the institutional level diminishes the time 
spent making study-related decisions at the scene of a cardiac arrest, where time is crucial 
to the delivery of life-saving care.   
2.7.6 Sample Size 
 
As previously noted, there have been no randomized controlled studies examining 
the effect of prehospital echocardiography on survival in OHCA. However, there have 
been a few randomized controlled studies that have examined the effect of other 
prehospital interventions on the survival of patients suffering OHCA. These studies vary 
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widely in terms of sample size. Nichol et al. enrolled a large sample size of 26,148 
participants in their trial, which spanned 114 EMS agencies. Hallstrom et al. enrolled a 
much smaller number of patients, totaling 1,071 participants. Both studies were able to 
achieve statistical significance in either primary or secondary outcomes with their 
respective approaches. 
2.7.7 Informed Consent in Emergency Research  
 
Obtaining consent for research in the prehospital setting can be quite challenging. 
Prehospital emergencies often occur in austere environments and require time-sensitive 
interventions. These challenges are further compounded when patients are unconscious, 
as is the case with OHCA patients. To address challenges in obtaining informed consent 
from patients in such dire circumstances, the Food and Drug Administration created a 
protocol named the Exception From Informed Consent (EFIC) in 1996.46 This policy 
exists to protect the rights of vulnerable patients while still promoting progress in medical 
research. According to the most recently updated guidelines, EFIC in emergency research 
situations “may only be conducted in unexpected, life-threatening circumstances where 
(1) the patient is incapacitated, (2) available treatments are unproven or unsatisfactory, 
(3) the proposed intervention may benefit the patient directly, and (4) the therapy must be 
initiated before consent from the [legally authorized representative] is feasible.”47 This 
allows the trial to proceed without requiring researchers to immediately obtain consent; 
instead, informed consent is obtained when the patient is no longer incapacitated, or a 
legally authorized representative, such as a spouse or family member, is available to 
provide informed consent for the patient. Furthermore, a “community consultation” is 
implemented to ensure that members of the community can reflect on the details of the 
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study and raise potential concerns. In a 2014 study investigating the implementation of 
community consultations across a variety of communities, it was found that the most 
prevalent consultation method was attendance at meetings of existing community 
groups.48 Knowledge of study content was high in these groups; increased study 
knowledge correlated with increased interactivity of the consultation.48 The FDA 
furthermore requires that following the completion of the proposed trial, public disclosure 
is initiated to inform the community of the results of the study. Therefore, in order to 
protect the rights of patients, we will use the FDA-approved EFIC guidelines. The 
informed consent form can be found in Appendix 3.   
2.8 Conclusion 
 
Current evidence in emergency research suggests that, despite the advancement of 
resuscitation techniques, survival rates in OHCA remain low. Portable ultrasound devices 
have emerged as a novel tool that may be used in the prehospital setting to visualize 
pathology contributing to cardiac arrest and other morbidity. One potential application of 
these devices is in the setting of cardiac imaging; several studies have found that 
echocardiography during the peri-resuscitative period in prehospital cardiac arrest may 
lead to changes in treatment. There is evidence to suggest that it is feasible to teach 
paramedics, who make up the bulk of ALS clinicians in the prehospital setting in the 
United States, to perform echocardiographic assessments, correctly analyze the images, 
and apply this knowledge to patient care. Confounding variables may be plentiful in the 
setting of OHCA and survival outcomes, but the crossover study design will likely 
mitigate many of these effects. Evidence from previous studies supports the selection of 
the primary and secondary outcomes, as well as inclusion and exclusion criteria proposed 
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in this study. Cluster randomization has also been adopted from previous studies as a 
potentially convenient way to randomize subjects in a crossover study design, without 
delaying patient care. Finally, a great deal of care has been taken to determine the most 
ethical way to obtain informed consent in the prehospital setting; this trial will use a 
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Chapter 3: Study Methods 
 
3.1 Study Design 
 
 We will perform a prospective randomized crossover study involving four 
Connecticut-based ground ambulance services. The services in question are divisions of 
American Medical Response, Inc employing both BLS and ALS clinicians in Hartford, 
New Haven, Waterbury, and Bridgeport. The four divisions employ roughly 450 ALS 
clinicians who can participate in the trial, approximately equally distributed between the 
four sites. An initial two-month training period will be devoted to didactic and clinical 
education designed to train paramedics to perform focused echocardiographic 
assessments during CPR. The four divisions will then be randomized to initially either 
perform standard resuscitation on enrolled subjects or perform resuscitation with the aid 
of a portable ultrasound device to guide chest compression positioning, with two 
divisions in each group. The two divisions initially selected to be in the intervention 
group will receive an appropriate number of portable ultrasound devices to be distributed 
to all ALS units for use during cardiac arrest responses. Every two months the divisions 
will switch protocols, for a total of 20 months. Patients enrolled in the study will be 
followed for a total of 30 days after enrollment. An additional 30-day period will be 

































3.2 Study Population and Sampling 
 
The study population will include adults 18 and older suffering non-traumatic 
OHCA. Patients will automatically be excluded in cases where cardiopulmonary 
resuscitation is not indicated, such as those with appropriate ‘do not resuscitate’ (DNR) 
or advance directive orders in place, or obvious signs of death (lividity, decapitation, 
transection, rigor mortis). Patients will also be excluded if they are known to be part of a 
vulnerable population; these include children (ages <18), pregnant women, and prisoners 
or wards of state. Sampling of patients will occur in a consecutive sampling method; 
patients will be enrolled when an ALS unit arrives on scene and determines that the 
patient is in cardiac arrest, provided he or she does not meet the exclusion criteria to the 
best of the responding paramedic’s knowledge. 
3.3 Subject Protection and Confidentiality 
 
Prior to the initiation of training, we will obtain institutional review board (IRB) 
approval by submitting an application according to the standard set in section 100 PR.1- 
Review by a Convened Institutional Review Board of Yale University. This application 
will include details of the process used to obtain informed consent as per guidelines of 
the Exception From Informed Consent emergency research protocol. The consent will 
explain the purpose of our research, procedures involved, and the duration of the study. It 
will also clearly delineate risks and discomforts of participation in the research protocol, 
as well as potential benefits. Though it will not be possible to obtain informed consent at 
the time of enrollment due to the nature of our research, informed consent will be 
obtained from the patient or a legally authorized representative as soon as possible. All 
data pertaining to patients will be deidentified wherever possible and stored in an 
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encrypted and password-protected server. Patients who do not wish to continue 
participating in the trial or have their data included in the study will have all data 
associated with their name removed from the server. Encryption of data, including 
protected health information, will be completed in accordance with the Health Insurance 
Portability and Accountability Act (HIPAA).  
As part of the EFIC guidelines for obtaining consent, we will also perform 
community consultations prior to the start of the trial but after IRB approval. The FDA 
requires community consultations to occur as a means of disseminating information about 
the study, including its risks and benefits. Prior to the start of the trial, we will take out 
several ads in local city newspapers (the Hartford Courant, the Waterbury Observer, the 
Connecticut Post, and the New Haven Register) detailing the goals, risks and benefits of 
participation in the trial, as well as details about where community consultations will 
occur and how enrollment will take place. After the study is complete, we will once again 
take out ads in these local newspapers reporting the findings of the study and thanking 
the community for its support and participation, as part of our public disclosure efforts. 
As previously discussed, acceptance of EFIC protocol and recall of relevant study 
details was highest when community consultations were held in existing community 
groups and had interactive measures.1 In order to provide the local community with an 
understanding of our proposed study and the enrollment process, we will plan a minimum 
of four community consultation gatherings during this time period. One community 
consultation will be performed in each of the communities that the four EMS agencies 
serve: Hartford, Waterbury, New Haven, and Bridgeport. Since the best results are 
produced when community consultations are held in existing community groups, the 
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scheduling of the consultations will depend on existing community gatherings at that 
time. The types of gatherings community consultations will occur in may include town 
hall forums, church groups, and club meetings. Community consultations will be 
advertised in advance. We will strive to ensure that attendance at the consultations is 
relatively equal across the four communities and will schedule additional consultations if 
necessary. During community consultations, we will explain pertinent study details, 
including risks and benefits of participation, as well as a description of the EFIC 
guidelines in layperson terms. At the conclusion of the meeting, surveys will be 
distributed to all participants to measure study detail recall and levels of agreement with 
EFIC enrollment. This process of community consultation will allow the members of the 
communities to develop basic knowledge of the trial and express any concerns that may 
need to be addressed prior to the start of the trial. Additionally, public disclosure of the 
findings of the study will provide the community with an understanding of the impact of 
the trial following its completion. 
3.4 Recruitment 
 
Whenever possible, an ALS unit staffed with an echocardiographic assessment-
trained paramedic is sent to any cardiac arrest call that occurs within the jurisdictions of 
the four EMS services. In cases where an alternative dispatch turns out to be a patient in 
cardiac arrest, an eligible ALS unit responds as soon as possible. Local first responders 
(such as the police or fire departments) also respond. Patients will be enrolled in the trial 
when an ALS unit arrives on scene of the call and the paramedic determines that the 
patient is in cardiac arrest and does not meet any exclusion criteria. Since randomization 
will be occurring at the institutional level, there will be no delay in delivering life-saving 
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treatment to the patient. Unfortunately, in cases of OHCA, patient demographics and 
causes of arrest are often unclear due to lack of bystander information and the patient’s 
inability to advocate for themselves. In cases where it is not clear whether the patient is in 
cardiac arrest due to a traumatic cause, the patient will be enrolled, but then later 
excluded in the final data analysis if he or she is found to have entered cardiac arrest 
because of trauma. Similarly, in cases where the patient does not appear to be a child, 
pregnant, or a prisoner, and there is no bystander information available to suggest 
otherwise, the patient will be assumed to not be a part of these vulnerable populations.  
3.5 Study Variables and Measures 
 
The intervention will be paramedic-performed focused transthoracic 
echocardiography using a portable ultrasound device performed during CPR. The control 
patients will receive standard CPR according to statewide EMS protocols without 
paramedic-performed focused transthoracic echocardiography.2 The primary dependent 
variable will be the proportion of patients surviving to hospital admission. Secondary 
variables will include the proportion of patients in whom chest compression position is 
adjusted, proportion of patients achieving ROSC, proportion of patients surviving to 
hospital discharge, and neurological function at discharge (scored on modified Rankin 
scale). 
3.6 Blinding of Intervention 
 
Patients will not be blinded to the intervention being performed, though most will 
be unresponsive for the duration of their resuscitation due to the nature of cardiac arrest. 
Therefore, the lack of subject blinding should not influence the results. The operators of 
the interventions (EMS personnel) also cannot be blinded to the intervention. Hospital 
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personnel cannot be reliably blinded to the intervention either, since the results of the 
echocardiography in the intervention group may lead to important changes in treatment of 
the patient that may be vital in the EMS report given to triage personnel.  
3.7 Blinding of Outcome 
 
This will be a single-blinded study. The assessor of the outcome will be blinded to 
whether each subject was in the control group or the intervention group. He or she will be 
asked to assess the subject’s medical record for survival data and neurological status, 
without any knowledge of whether the subject received the intervention. 
3.8 Assignment of Intervention 
 
The initial randomization of the intervention among the four EMS services will be 
performed by a computer program.  Once randomized, the two pairs of services will swap 
intervention/control every 60 days for the duration of the study; hence, randomization 
will only occur once. 
3.9 Adherence 
 
Since the implementation of the intervention depends largely on the paramedics 
providing primary treatment during a cardiac arrest, there will be several initiatives in 
place to encourage their adherence to the protocol. A small monetary reward in the form 
of a $20 Starbucks gift card will be awarded to all eligible paramedics who enroll patients 
and use the intervention in at least 75% of eligible cardiac arrest patients they respond to. 
Furthermore, in cases where eligible patients are not enrolled by paramedics, it will be 
mandated that a “Non-Enrolled Patient” form be completed and reviewed to examine the 
reasons for not implementing the intervention (see Appendix 1). Paramedics will be 
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required to sign the portable ultrasound devices out of the office with their charging 
devices and return them at the end of their shift with details of any issues or damages that 
may have occurred during the shift. Unfortunately, several prior studies have described 
issues with paramedics adhering to study protocols in trials involving prehospital 
interventions.3,4 We believe that establishing several safeguards in place to encourage use 
of the portable ultrasound devices will limit bias and confounding, and help enroll the 
necessary number of participants to meet the required sample size.  
3.10 Monitoring of Adverse Events 
 
Similar studies have monitored a variety of adverse events in patients suffering 
OHCA.5,6 Using these studies as a frame of reference, we will review patient charts for 
the following adverse events: death, re-arrest, pulmonary edema, seizure, chest fracture, 
pneumothorax, hemothorax, cardiac tamponade, cerebral bleeding, aspiration, and 
internal organ injury. These are adverse events that can occur as a result of the aggressive 
resuscitation performed during CPR or ACLS. Paramedics will be asked to comment on 
adverse events in the enrolled patient forms. Information about subsequent adverse events 
will be obtained from the patient’s medical record. The intervention itself (applying the 
ultrasound probe to the chest) does not have any known serious adverse effects.  
3.11 Data Collection 
 
Data will be collected continually throughout the course of the trial. After the 
initial two-month training period is complete, the 20-month enrollment period will begin. 
Paramedics will be expected (and incentivized as above) to enroll eligible patients into 
the trial when they are dispatched to cardiac arrests. Paramedics in the intervention group 
will perform patient care as specified in the state protocols, with the only exception being 
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the use of the portable ultrasound device during chest compression intervals.2 Paramedics 
who enroll a patient into the trial will be expected to fill out a “Cardiac Arrest Trial 
Enrollment Form” detailing whether they were able to elicit an adequate view using the 
portable ultrasound device, whether the left ventricle was being adequately perfused, and 
whether the imaging resulted in a change in compression positioning or patient 
management (Appendix 2). A short narrative will be written detailing any changes in 
patient management. Paramedics who do not enroll an eligible patient will complete a 
similar form explaining why they were unable to or did not wish to comply with the trial 
guidelines. Paramedics will be required to fill out the necessary forms the same day of 
their shift to maximize retention. We hope that these forms will shed light on the factors 
that contribute to changes in patient management, as well as possible equipment and 
compliance issues, without interfering with or delaying emergent patient care at the time 
of cardiac arrest. 
 Additional data on survival and adverse events will be collected from EMS run 
forms and hospital records. Data will be collected in the electronic medical records at 
Yale New Haven Hospital, Saint Francis Hospital, Hartford Hospital, Hospital of Central 
Connecticut, Saint Vincent’s Hospital, Bridgeport Hospital, Waterbury Hospital, and 
Saint Mary’s Hospital. A 30-day follow-up period ensures that we are able to collect the 
necessary data from patients who may be hospitalized for extended periods of time 
following cardiac arrest. Any patient who subsequently refuses to participate in the trial 
will have his or her records expunged from all data collected in this trial. 
42 
 
3.12 Sample Size Calculation  
We are planning a study in which subjects will be randomized to either the 
intervention or control at the institutional level at an approximately equal ratio. The 
calculation of sample size is based on comparison of rates of survival to hospital 
admission in a population of patients suffering OHCA receiving standard care, and is 
averaged from several studies including those by Aichinger et al7, Nichol et al6, 
Hallstrom et al.8, and Aufderheide et al5. The average rate of survival to hospital 
admission in the control groups of these studies is 24%. The study will be powered at 
80%, with a type I error of 5%. Currently there are no randomized, controlled studies 
available on the use of ultrasound in prehospital cardiac arrest and its effect on survival.9 
We are aiming to observe a 5% increase in the proportion of patients surviving to hospital 
admission in the intervention group; this effect size was used in a similar study by 
Aufderheide et al.5 Therefore, the calculated sample size is 1,222 patients in each group, 
for a total of 2,444 participants. See Appendix 6 for further sample size calculation 
details. 
3.13 Statistical Analysis 
 
Descriptive statistics will include age, sex, BMI, comorbidities, presumed cause 
of cardiac arrest, downtime (in minutes), location of arrest (whether public), bystander 
witness of arrest, bystander CPR, initial rhythm present, length of resuscitation (in 
minutes), time from 9-1-1 call to arrival of unit (in minutes), and time between arrival of 
EMS and CPR initiation (in minutes). Analysis will be performed under the intention-to-
treat protocol. A significance level will be set as p≤0.05. Continuous variables will be 
represented as parametric means with standard deviation and will include the following: 
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age, BMI, downtime, length of resuscitation, time from 9-1-1 call to arrival of unit, and 
time between arrival of EMS and CPR initiation. If any of the baseline characteristics are 
found to be nonparametric, they will be represented as medians with interquartile ranges 
instead. Sex, occurrence of arrest in public area, bystander witness of arrest, and 
bystander CPR will be analyzed as proportions. Finally, comorbidities, presumed cause 
of arrest, and initial rhythm present will be analyzed as relative frequencies. The primary 
outcome, survival to hospital admission, will be analyzed as a proportion with 
McNemar’s test due to the matching of crossover groups. Although the crossover study 
design minimizes the likelihood of imbalance of confounding variables between groups, 
multivariate analysis may need to be performed. In this case, a conditional logistic 
regression model will be used. Secondary variables analyzed using McNemar’s test will 
include proportion of patients in whom chest compression position is adjusted, proportion 
of patients achieving ROSC, and proportion of patients surviving to hospital discharge. 
Neurological function at discharge (scored on modified Rankin scale) will be analyzed as 
a median using the Wilcoxon signed-rank test. With the exception of neurological 
function, which will be analyzed using the ordinal logistic regression model, multivariate 
analysis of all other secondary outcomes will be performed using the conditional logistic 







Table 1: Descriptive characteristics of enrolled patients 
 
3.14 Timeline and Resources 
 
The study period will be 24 months, beginning in January 2021. Prior to this time, 
we will request approval from the Human Investigation Committee, which will take 
approximately 3 months. From January 1, 2021 – March 1, 2021, paramedics in the four 
AMR agencies will be assigned to didactic echocardiography training. Previous studies 
have shown that paramedics can successfully obtain good images of the heart following a 
single day of training that incorporates both didactic and practical sessions.4,10 A two-
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hour didactic lecture will be followed by a two-hour long period of practice on an 
ultrasound simulator and practice on volunteers. The didactic session will focus on using 
the parasternal long axis (PSLA) and subxiphoid views for identification of the following 
components of echocardiography: movement (presence of), function (quality of), and 
chambers (particularly the left ventricle).10 The simulation and practice session will be 
necessary to ensure that paramedics become comfortable with the equipment and learn 
how to use it to obtain the correct views. The goal of the training will be to obtain a 
satisfactory view of the left ventricle from the two views while compressions are being 
simulated in <30 seconds. Paramedics will complete a short quiz at the end of the four-
hour classroom training to test their knowledge and new skills. Paramedics will be shown 
ultrasound clips and asked to identify the left ventricle and its quality of function. 
Paramedics will also briefly be tested on their ability to obtain PSLA and subxiphoid 
views on a volunteer in under 30 seconds. Paramedics who score <70% on the 
administered quiz will be required to attend refresher training prior to participating in the 
trial.  
Following the four hours of classroom training and quiz, each paramedic will also 
complete a scheduled 12-hour training shift in his or her sponsor hospital’s emergency 
department, to practice performing the echocardiographic assessment on living patients. 
If a patient in cardiac arrest presents to the emergency department, the paramedic will 
have the opportunity to perform the echocardiographic assessment on the patient in 
cardiac arrest. Paramedics who are newly hired after the trial has started, or those who 
require additional training, will have the opportunity to attend a four-hour “refresher” 
training session held monthly at one of the central stations of the EMS agencies. 
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 From March 1, 2021 – November 1, 2021, patients will be enrolled into the study 
by trained paramedics. This 20-month period ensures that there is ample time to enroll 
enough patients to reach the desired sample size. A 30-day follow-up period will begin 
once the enrollment period is over. We estimate that an additional 30-day period will be 
required for data analysis. The equipment requirement for this study will be 
approximately 60 portable ultrasound devices. This is estimated based on the 
approximation of 30 ALS units available for coverage on a given day at each EMS 
agency. Since only half of the agencies will have portable ultrasound devices at any given 
time, we can purchase enough portable ultrasound devices to be used at two agencies 24 
hours a day. We will use Butterfly IQ probes, which are relatively small and durable, and 
thus likely to survive the harsher conditions in the field relative to hospitals. At 
approximately $2000 a unit, we estimate that the total cost of the devices will be 
approximately $120,000. Paramedics will use their own smartphones to connect to the 
device and view images, whenever possible. We will approach the manufacturer 
regarding providing portable ultrasound devices at a discounted rate due to the volume of 
the order. The study will also require a minimum of one training instructor to deliver 
didactic and hands-on training. We will also need to employ a project oversight manager 
to collect data from the EMS agencies and ensure it is properly entered into the project 
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Chapter 4: Conclusion 
 
4.1 Advantages and Disadvantages 
 
 The trial we have proposed here has several advantages. The intervention we are 
implementing makes use of technology that is both effective and relatively inexpensive. 
The study we have proposed investigates the effect of portable ultrasound technology in 
the prehospital setting on survival to hospital admission, which has not been studied in 
this context. As such, the results gathered from this study may provide the first data 
available on the effect of this type of technology on survival in the prehospital setting. 
The primary and secondary outcomes will provide data on survival to both hospital 
admission and discharge, as well as neurological function at discharge. These data may 
provide some insight not only on the survivability of cardiac arrest, but long-term patient 
health as well. The study design is a randomized prospective crossover trial, which has 
several benefits. The crossover design allows for greater convenience and decreases 
costs, because it allows researchers to purchase fewer pieces of equipment. Because each 
participant is matched due to the inherent structure of the crossover design, confounding 
is mitigated. Another benefit of the study we have proposed is that it incorporates 
paramedics from American Medical Response, Inc, a corporation that already has several 
structured EMS agencies across Connecticut, and a national commitment to advancing 
EMS research. The four EMS agencies we will be using to enroll patients cover diverse 
and widespread areas of Connecticut, encompassing urban, suburban, and rural 
communities. This ensures that we will be able to enroll participants from different 
backgrounds with a wide variety of baseline characteristics. This in turn will allow for 
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greater generalizability of results. Furthermore, because the four agencies collectively 
employ approximately 450 paramedics and staff approximately 120 on any given day, we 
will easily be able to enroll an adequate number of participants in our study to meet the 
required sample size and appropriately power the study. We have determined that it is 
feasible to train paramedics to perform and analyze the assessment we have proposed, as 
described in Chapter 2. The paramedics who participate in our study will undergo a 
training period that is extensive enough to ensure that they have all the necessary skills to 
perform the echocardiographic assessment, based on data from prior studies.1-3 The study 
timeline, which incorporates a 20-month participant enrollment period, allows ample time 
to meet the sample size. The 30-day follow-up period additionally ensures that patients 
who survive to hospital admission and remain admitted can be followed for an additional 
month to track secondary outcomes.  
 Although our proposed study has many advantages, there are also several 
disadvantages associated with the nature of prehospital medicine. Unfortunately, it is 
impossible to obtain traditional informed consent in a prehospital setting where patients 
are unconscious. We will utilize the EFIC protocol to obtain informed consent from the 
participant or a legally authorized representative as soon as possible, but this process is 
not ideal.4 However, this currently remains the only viable way to perform research in 
emergency medicine when participants are incapacitated. Another challenge to our 
study’s validity that may arise is the possible lack of adherence to study protocols by 
participating paramedics, which is an issue that has arisen in other studies using 
paramedics in the prehospital setting.5 Ketelaars et al. found that due to many different 
possible factors (including lack of time, forgetfulness, and perceived lack of “usefulness” 
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of the images obtained), paramedics often omitted data or case report forms from the 
trial, resulting in unwanted selection bias. These issues may certainly arise in our 
proposed study, but we have taken several steps to preemptively prevent this. Paramedics 
will be offered a small monetary incentive for enrolling patients and filling out the 
associated form (see Appendix 2). Furthermore, paramedics will also be required to 
submit paperwork when they fail to enroll patients (see Appendix 1) to determine where 
and why the failure occurred.  
4.2 Clinical and/or Public Health Significance 
 
As previously described, there currently are no randomized controlled studies 
available examining the effect of prehospital ultrasound use on survival. Our proposed 
study will result in the first set of data that examines how the use of ultrasound in the 
prehospital setting affects survival rates. Because portable ultrasound devices may seem 
to be a large monetary investment to many small EMS agencies, ultrasound technology is 
still not widely available in the prehospital setting. If found to be positive, the evidence 
garnered in this study could help support the decision to purchase ultrasound devices or 
apply for grants or funding from local organizations to do so. Additionally, the data from 
this study could have implications for how CPR is currently standardized. Since body 
habitus and anatomical variations are currently not accounted for when performing CPR, 
the data from this trial may show whether this needs to change to involve an 
individualized approach to resuscitation. CPR is one of the most important components 
of early care of cardiac arrest, yet it relies on the assumption that every person’s body 
will be identically receptive to compressions. With the findings from this trial, we may be 
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able to provide evidence to support a new method of CPR delivery that accounts for 
individual anatomy.  
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Appendix 3: EFIC Consent Form 
 
COMPOUND AUTHORIZATION AND CONSENT FOR PARTICIPATION IN A 
RESEARCH STUDY 
 
YALE UNIVERSITY SCHOOL OF MEDICINE 
YALE-NEW HAVEN HOSPITAL 
 
Study Title: Effect of prehospital echocardiography in cardiac arrest to augment 
positioning of chest compressions  
Principal Investigator (the person who is responsible for this research): Alexandra 
Zhakov 
Phone Number: (860) 816-6356  
Research Study Summary: 
• We are asking you to continue being a part of our research study. 
• The purpose of this research study is to determine whether the use of paramedic-
guided echocardiography during cardiopulmonary resuscitation in out-of-hospital 
cardiac arrest results in higher rates of survival to hospital admission. 
• Study procedures will include: There are two groups in this project. You were 
enrolled in one of the two groups based on which branch of emergency medical 
services responded to your 9-1-1 call for help. One group received the intervention, 
which is the use of echocardiography during cardiopulmonary resuscitation. The 
other group is the control, which means that people in this group receive standard 
cardiopulmonary resuscitation as dictated by Connecticut emergency medical services 
protocols. 
• There are no risks to continuing your participation in this study. 
• Taking part in the continuation of this study is your choice. You can choose to take 
part, or you can choose not to take part in this study.  You can also change your mind 
at any time.  Whatever choice you make, you will not lose access to your medical 
care or give up any legal rights or benefits.  
• If you are interested in learning more about the study, please continue reading, or 
have someone read to you, the rest of this document. Take as much time as you need 
before you make your decision. Ask the study staff questions about anything you do 
not understand. Once you understand the study, we will ask you if you wish to 





Why is this study being offered to me? 
We are asking you to take part in a research study because you suffered an out-of-
hospital cardiac arrest and were given life-supporting care by emergency medical 
services personnel.   
 
Who is paying for the study? 
Yale School of Medicine Physician Associate Program  
 
What is the study about?  
The purpose of this study is to determine whether the use of transthoracic 
echocardiography during cardiopulmonary resuscitation will lead to higher rates of 
survival to hospital admission. Transthoracic echocardiography is performed using a 
Butterfly IQ portable ultrasound device, which was FDA-approved in 2017 for many 
clinical purposes, including cardiac imaging. We use the Butterfly IQ ultrasound probe to 
image the heart while it is being compressed during cardiopulmonary resuscitation.  
 
What are you asking me to do and how long will it take?  
You are being asked to continue to participate in this study because you suffered a 
medical cardiac arrest outside of a hospital, and a bystander or loved one called 9-1-1 to 
activate emergency medical services for help. The dispatcher sent an ambulance with 
personnel who had advanced life support credentials. These personnel, the paramedics, 
were instructed on how to follow this study’s protocols without delay of emergency care. 
The paramedic assessed you, and instructed others to begin life-saving care. At the same 
time, he or she determined that you met other criteria (such as being an adult, not 
pregnant, not having any “do not resuscitate” directives, and not having been involved in 
a traumatic event causing the cardiac arrest). You met enrollment criteria, and the 
paramedic determined that you could participate in the trial. However, he or she did not 
randomize you to the intervention or control group at that time. Randomization had 
already occurred at the institutional level, meaning the paramedic was told in advance 
whether the patients he or she enrolls will be in the intervention group or control group. 
Unfortunately, the paramedic was not able to obtain informed consent from you or a 
legally authorized representative at that time, because you were unresponsive and 
delaying care would have been unethical. In cases like these, researchers are able to 
enroll you in an emergency research trial provided that you or a legally authorized 
representative give informed consent to continue participating in the trial as soon as 
possible. 
 
If you were in the control group, you received standard care, including cardiopulmonary 
56 
 
resuscitation, as per statewide emergency medical services protocols. This means that the 
paramedic and the rest of the emergency team did everything in their power to resuscitate 
you. If you were in the intervention group, the paramedic and the rest of the team 
delivered the same exact care as directed by statewide protocols, with one small 
exception. While a member of the team was performing chest compressions to re-perfuse 
your heart, the paramedic used a small, portable ultrasound probe to visualize your heart 
by placing it over your chest. The probe uses soundwave technology to show an image of 
the heart to the paramedic in real time. The images received by the probe allowed the 
paramedic to determine whether the heart was pumping effectively during CPR, or 
whether a small adjustment in positioning of chest compressions needed to be made. If 
so, the paramedic would have asked the teammate performing chest compressions to 
adjust his or her form, without interrupting CPR. This should not have affected your care 
in any detrimental way, because CPR was not paused. The rest of your care was also not 
changed.  
 
You were transported to the hospital, and there you were registered and your care 
continued as usual. Since the study aims to determine whether there will be an increase in 
survival to hospital admission, an outcome assessor will need to view your medical 
record, but he or she will not know whether you were in the intervention or control group.  
Your consent is needed to use the information we have already collected, and to have the 
outcome assessor view your record.  
 
What are the risks and discomforts of participating?  
There are minimal side effects associated with transthoracic echocardiography. This 
intervention is not invasive. It involves placing a probe on the skin over your heart and 
taking an image.  This already took place; no further interventions are involved. 
Direct side effects: 
The main side effects that other people have experienced so far with transthoracic 
echocardiography is discomfort from the ultrasound probe.  However, this already took 
place. 
Additional side effects: 
 
Another risk may be the paramedics’ inexperience with a new tool. Paramedics have been 
trained to use the ultrasound probe with the explicit request that no other aspects of 
patient care change. However, there are other paramedics present on the team that 
responded to your emergency, who have not been previously exposed to this device. We 
cannot guarantee that there were no changes to the speed with which care is delivered by 
these personnel, as they adjust to the implementation of a new device in the resuscitation 
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algorithm. Every effort has been made to train the paramedics involved in this protocol to 
limit the amount of time spent performing the intervention in order to limit distractions 
and delays in care. If you have questions, you can talk to the project director about 
whether this risk may have applied to you. 
Reproductive risks: 
We do not know if the intervention causes harm to a baby, so we do not want anyone 
who might be pregnant to enter the project. 
 
How will I know about new risks or important information about the study?  
We will tell you if we learn any new information that could change your mind about 
taking part in this study.  
 
How can the study possibly benefit me? 
This study may or may not help you, but we hope the information from this study will 
help us develop better treatments for cardiac arrest. This intervention is unlikely to 
worsen your condition. Cardiac arrest, especially when occurring outside of a hospital, 
has a very low survival rate. Your chances of survival depend largely on how well your 
heart is perfused after you suffer a cardiac arrest. This intervention will attempt to lessen 
the amount of time that your heart, brain, and other vital organs are poorly perfused. If 
successful, this intervention may increase the likelihood of survival from cardiac arrest. 
 
How can the study possibly benefit other people? 
The benefits to science and other people may include a better understanding of how CPR 
can be tailored to each individual person’s anatomy.   
 
Are there any costs to participation? 
You will not have to pay for taking part in this study.  
 
Will I be paid for participation?  





How will you keep my data safe and private? 
We will keep information we collect about you confidential. We will share it with others 
if you agree to it or when we have to do it because U.S. or state law requires it.  We will 
keep all data related to your care password protected in a secure database. 
When we publish the results of the research or talk about it in conferences, we will not 
use your name or other identifying information, such as your address or date of birth.  We 
will also not share information about you with other researchers for future research. 
 
What Information Will You Collect About Me in this Study? 
The information we are asking to use and share is called “Protected Health Information.” 
It is protected by a federal law called the Privacy Rule of the Health Insurance Portability 
and Accountability Act (HIPAA). In general, we cannot use or share your health 
information for research without your permission. If you want, we can give you more 
information about the Privacy Rule. Also, if you have any questions about the Privacy 
Rule and your rights, you can speak to Yale Privacy Officer at 203-432-5919. 
The specific information about you and your health that we will collect, use, and share 
includes: 
 
• Research study records 
• Medical and laboratory records of only those services provided in connection with 
this Study.   
• The entire research record and any medical records held by the fire department that 
responded to your cardiac arrest (if any), American Medical Response, Inc. 
(if they transported you to the hospital), and associated hospitals created 
from: 1/1/2021 to: 1/1/2023  
• Records about phone calls made as part of this research 
• Records about your study visit 
• Information obtained during this research regarding 
▪ Records about your medical condition 
▪ Records about the study device 
How will you use and share my information? 
We will use your information to conduct the study described in this consent form.  
We may share your information with: 
• The U.S. Department of Health and Human Services (DHHS) agencies 
• Representatives from Yale University, the Yale Human Research Protection 
Program and the Institutional Review Board (the committee that reviews, approves, 
and monitors research on human participants), who are responsible for ensuring 
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research compliance.  These individuals are required to keep all information 
confidential.  
• The U.S. Food and Drug Administration (FDA) This is done so that the FDA can 
review information about the portable ultrasound device involved in this research.  
The information may also be used to meet the reporting requirements of drug 
regulatory agencies.   
• The study sponsor or manufacturer of study drug/device 
• Co-Investigators and other investigators  
• Study Coordinator and Members of the Research Team  
• Data and Safety Monitoring Boards and others authorized to monitor the conduct of 
the Study  
We will do our best to make sure your information stays private. But, if we share 
information with people who do not have to follow the Privacy Rule, your information 
will no longer be protected by the Privacy Rule. Let us know if you have questions about 
this. However, to better protect your health information, agreements are in place with 
these individuals and/or companies that require that they keep your information 
confidential. 
Why must I sign this document? 
By signing this form, you will allow researchers to continue to use and disclose your 
information described above for this research study. This is to ensure that the information 
related to this research is available to all parties who may need it for research purposes. 
You always have the right to review and copy your health information in your medical 
record.  
What if I change my mind? 
The authorization to use and disclose your health information collected during your 
participation in this study will never expire.  However, you may withdraw or take away 
your permission at any time. You may withdraw your permission by telling the study 
staff or by writing to Alexandra Zhakov at the Yale University, New Haven, CT 06520. 
If you withdraw your permission, you will not be able to stay in this study but the care 
you get from your doctors outside this study will not change.  No new health information 
identifying you will be gathered after the date you withdraw. Information that has already 
been collected may still be used and given to others until the end of the research study to 
insure the integrity of the study and/or study oversight.   
 
What if I want to refuse or end participation before the study is over?  
Taking part in this study is your choice. You can choose to take part, or you can choose 
not to take part in this study.  You also can change your mind at any time.  Whatever 
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choice you make, you will not lose access to your medical care or give up any legal rights 
or benefits.  
 
We would still treat you with standard therapy or, at your request, refer you to a clinic or 
doctor who can offer this treatment. Not participating or withdrawing later will not harm 
your relationship with your own doctors or with this institution.   
 
To withdraw from the study, you can call a member of the research team at any time and 
tell them that you no longer want to take part.   
 
The researchers may withdraw you from participating in the research if necessary. This 
may occur if you are discovered to not meet enrollment criteria, such as if you are: 
pregnant, under 18 years of age, a prisoner, or ward of state. 
What will happen with my data if I stop participating? 
If you decide to stop participating in the study, all data and images associated with your 
name will be deleted from our database. 
 
Who should I contact if I have questions?  
Please feel free to ask about anything you don't understand.  
 
If you have questions later or if you have a research-related problem, you can call the 
Principal Investigator at (860) 816-6356).  
 
If you have questions about your rights as a research participant, or you have complaints 
about this research, you call the Yale Institutional Review Boards at (203) 785-4688 or 
email hrpp@yale.edu. 
 
Authorization and Permission 
 
Your signature below indicates that you have read this consent document and that you 




We will give you a copy of this form. 
 
 
Participant Printed Name    Participant Signature  Date 
Person Obtaining Consent 
Printed Name 




Legally Authorized Representative 
Name 
 LAR Signature  Date 
 
 
Complete if the participant is not fluent in English and an interpreter was used to 
obtain consent.  Participants who do not read or understand English must not sign this 
full consent form, but instead sign the short form translated into their native 
language.  This form should be signed by the investigator and interpreter only.  If the 





Print name of interpreter: ______________________________________ 
 
Signature of interpreter: ___________________________________    Date: 
_________ 
 
An oral translation of this document was administered to the participant in 
_____________ (state language) by an individual proficient in English and 
____________ (state language).  
Print name of impartial witness: __________________________________ 
 


































Image 1: The Butterfly IQ probe attaches to smartphones and will be used by the 
paramedic to visualize the left ventricle during cardiac arrest. It contains a built-in battery 
which can be wirelessly charged. The device can perform up to 2 hours of continuous 
























Appendix 5: Modified PSLA and Subxiphoid Views Obtained During CPR 
 
The following images (provided by Liu et al.) depict how a clinician obtains the PSLA 
and subxiphoid views while chest compressions are in progress.2 
 
Image 1: A clinician obtains a modified PSLA view while another administers manual 
chest compressions. 
 




1. Liu RB, Bogucki S, Marcolini EG, et al. Guiding Cardiopulmonary Resuscitation 




Appendix 6: Sample Size Calculation 
 
Sample size based on a proportion calculator with assumed normal distribution. 
- Alpha (a) = 0.05 (two-tailed) 
- Beta (b) = 0.20, corresponding to 80% power 
- Risk in control group = P0 = 0.24 
- Risk in intervention group = P1 = 0.29 
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